Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to streamline diagnostics pathways for (a) companion and (b) other diagnostics.

The Elective Reform Plan, published in January 2025, announced that the integrated care boards (ICBs) will make optimal use of the new diagnostic capacity by implementing the new standards for community diagnostic centres (CDCs) and hospital-based diagnostic services, in particular increasing direct referrals and rolling out at least 10 straight-to-test pathways by March 2026.

To date, NHS England has agreed three national CDC diagnostic pathways which ICBs will be expected to implement by March 2026. These are: breathlessness; children and young people’s asthma; and unscheduled bleeding on hormone replacement therapy.

NHS England is working with clinicians to best determine other priority straight to test pathways, including in CDCs. Implementation of these pathways will deliver the expectations in the Elective Reform Plan for significant elective care reform to be delivered in at least five specialties, those being: ear nose and throat; gastroenterology; respiratory; urology; and cardiology. Wider clinical pathway optimisation work will also centre around these specialities.

The National Cancer Plan will include further details on how we will improve outcomes for cancer patients, as well as speeding up diagnosis and treatment, ensuring patients have access to the latest treatments and technology, and ultimately bringing this country’s cancer survival rates back up to the standards of the best in the world.  The plan will also look at how we can maximise our impact through the most up-to-date technology and innovations. It will ensure that we continue to maximise the access to, and the impact of, clinical trials in diagnostics and treatments.